Baba Ramdev stretches out an empire

April 14, 2016

Apr 14: The company, which is striking fear into its current and potential competitors, expects to report revenue of $750 million in the fiscal year that ended in March, more than double the previous year’s $300 million.

ramdev

The Sitting on an orange sofa set over a Persian carpet, in a gated office park of freshly painted tan buildings and manicured lawns, Baba Ramdev is surrounded by the trappings of any major corporate leader almost anywhere in the world.

But Ramdev is also an Indian swami, having renounced all worldly pleasures and possessions, and he sits cross-legged on the couch, his face fringed by an untamed beard, his body draped in the saffron cloth of a Hindu holy man.

Famous for bringing yoga to the Indian masses, Ramdev, 50, is also the leader of what has become known as the “Baba Cool Movement” — a group of spiritual men, known as “babas.”

They are marketing health-based consumer items based on the ancient Indian medicinal system of herbal treatments, known as Ayurveda. His rapidly expanding business empire of packaged food, cosmetics and home-care products is eating into the sales of both multinational and Indian corporations.

The babas’ message about the value of traditional Indian ingredients is particularly resonant in the current environment in India, where a prime minister and his political party have built a narrative around the value of ancient Hindu practices, from yoga to reverence for cows.

Ramdev is the most prominent of a growing group of brand-building babas, whose ranks include Sri Sri Ravi Shankar, the founder of the Art of Living, an Indian spiritual practice, who promotes a line of creams, soaps and shampoos also called Ayurveda.

“There is truly a tectonic shift” in the consumer products business in India, said Harish Bijoor, a brand strategy specialist and former head of marketing at a subsidiary of the big conglomerate Tata Group.

Ramdev and his friend and business partner, Acharya Balakrishna, 44, run Patanjali Ayurved Limited from a corporate headquarters in Haridwar, ancient city on the banks of River Ganga in Uttarakhand. In an interview, Ramdev said he was the creative force and public face of Patanjali, even though, as a swami, he does not have an official title or hold any shares of the privately held company.

Rising at 3:30 am each day to drink the juice of the amla fruit, berry rich in vitamin C and considered the top immunity booster in Ayurveda medicine, he unleashes a torrent of new product ideas — an herbal energy bar, an herbal hair dye, a sugar-free immune booster — that he records in large Hindi script in a spiral bound notebook. Then he plunges into three hours of yoga, followed by a 12-hour day that is split between Patanjali business and the public meetings of a spiritual and political leader.

Balakrishna, as the managing director, runs day-to-day operations. “Without him, nothing would be possible,” Ramdev said of his partner, who paced in the office as the interview with the loquacious swami spilled over its one-hour allotment.

The two men met in the 1990s when they studied at the same gurukul, a residential school that was the norm for Indian Hindus before the British arrived. Both the sons of farmers, they went on together to study in the Himalayas, Ramdev focusing on yoga and Balakrishna on Ayurveda.

In 1994, they founded the first of three charitable trusts, to run a hospital and a university dealing in Ayurvedic medicine, and an ashram. There, they held yoga camps and free health checkups at which they dispensed Ayurveda treatments, which are largely herbal. Before long, they had set up a manufacturing plant for Ayurveda products.

Around the same time, Ramdev began his televised yoga classes. Lean and muscular, Ramdev proved to be a telegenic tour de force, bringing yoga to India’s poor and the growing middle class. He gradually ventured beyond yoga to become a public critic of government corruption, leading a mass protest in New Delhi in 2011 and later endorsing Prime Minister Narendra Modi during the election in 2014.

Modi and his BJP swept to power soon after, unleashing a strong Hindu nationalist sentiment that Ramdev says has created “an ideal ecosystem” to support his business. Modi pushed the United Nations to create International Yoga Day, and he inaugurated it last year, with Ramdev by his side, in a nationally televised ceremony involving 35,000 people.

Ramdev, given to raucous laughter and bouts of giggles that make him seem disarmingly humble, can just as suddenly overflow with bravado, as he did when asked about the source of Patanjali’s popularity and power. “People buy our products because they believe I will only sell them good things,” he said. Beyond Ramdev’s appeal, Patanjali products are attractive because they are high quality and prices are about 20% lower than the competition, analysts said.

It is not clear how Patanjali is able to charge such low prices, given that its profit margin of 13% is within the industry range of 13 to 16%. Ramdev ventured that, with his fame, his advertising costs are much lower than those of his competitors, who spend as much as 15% of their revenue promoting their products.

The faces of Ramdev and Balakrishna adorn almost every building, billboard and truck connected to the company, which is expanding so fast it is striking fear into its current and potential competitors. The company expects to report revenue of $750 million in the fiscal year that ended in March, more than double the previous year’s $300 million, the two men said.

Meteoric rise

Credit-Suisse Securities, in a report early this year, said Patanjali’s “meteoric rise” had hurt Colgate-Palmolive (India) Ltd, which is majority owned by the US-based Colgate-Palmolive. Sales of Colgate’s toothpastes slowed from growing at about 10% annually just 1% in the quarter ending in December, in the face of competition from Patanjali, Rohit Kadam, the analyst who wrote the report, said in an interview.

The report said sales of health supplements at Dabur India Ltd, one of the country’s largest consumer goods companies, had been growing at close to 20% annually but began falling at the end of last year, hurt by competition from Patanjali. In the face of that threat, Patanjali’s competitors “are working on overdrive to create similar types of product options,” Bijoor, the brand strategist, said.

Colgate has introduced toothpastes containing the extract of neem and charcoal, both still used by villagers to clean their teeth. Spokesmen for Colgate and Dabur did not respond to requests for comment. Experts say that for the foreseeable future, the only danger signs for Patanjali is the enthusiasm of its founder, Ramdev.

If he takes it “a bit too far, he’ll lose new customers,” said Sunil Alagh, a business consultant and formerly chief executive of Britannia Industries Ltd, famous for packaged cookies. In the past, Ramdev had dived into controversial conservative causes without hesitation. Last year, for example, he claimed that he could cure homosexuality by treating a person with yoga.

Ramdev was also outspoken in his condemnation of a student at a New Delhi university who faced sedition charges after the authorities accused him of participating in a pro-Pakistan campus rally. “The traitors,” Ramdev said, “must be arrested.”

Controversy aside, Bijoor has predicted that the “Baba Cool Movement” would eventually outsell both multinationals and top Indian companies alike. “It’s about a good connect,” he said. “It’s about becoming the umbilical cord connecting the past to the present.”

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 8,2020

New Delhi, Jun 8: Delhi Chief Minister Arvind Kejriwal has gone into self-quarantine after developing sore throat and fever, and will get himself tested for COVID-19 on Tuesday, officials said on Monday.

They said the chief minister, who is also a diabetic, was feeling unwell since Sunday afternoon.

"He has mild fever and sore throat since Sunday afternoon. As advised by doctors, the chief minister will undergo COVID-19 test on Tuesday morning," officials said.

Officials said the CM had attended a Cabinet meeting on Sunday morning and thereafter, he did not attend any meeting.

The chief minister has been holding most of his meetings via video conferencing from his official residence for past two days.

This come as the number of coronavirus cases in the national capital crossed the 28,000-mark with 1,282 fresh infections while the death toll climbed to 812 on Sunday, a health bulletin issued by the Delhi government said. According to the health bulletin, the total number of COVID-19 cases in Delhi rose to 28,936 with 1,282 fresh cases.

A total of 51 fatalities were reported on June 6, the bulletin said, adding that these lives were lost between May 8 and June 5. It, however, said the cumulative death figure refers to fatalities where the primary cause of death was found to be COVID-19, according to a report of the Death Audit Committee on the basis of the case-sheets received from various hospitals.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 30,2020

Hyderabad, Jun 30: Hyderabad-based Bharat Biotech announced that it has successfully developed Covaxin, India's first vaccine candidate for Covid-19, in collaboration with the Indian Council of Medical Research (ICMR) and National Institute of Virology (NIV).

The Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II Human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response. Human clinical trials are scheduled to start across India in July 2020.

The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech.

The indigenous, inactivated vaccine developed and manufactured in the company's Bio-Safety Level 3 (BSL-3) High Containment facility located in Genome Valley, Hyderabad.

Announcing the vaccine development milestone, Dr Krishna Ella, Chairman and Managing Director said: "We are proud to announce COVAXIN, India's first indigenous vaccine against COVID-19. The collaboration with ICMR and NIV was instrumental in the development of this vaccine."

Dr Ella added, "The proactive support and guidance from CDSCO has enabled approvals to this project. Our R&D and Manufacturing teams worked tirelessly to deploy our proprietary technologies towards this platform."
Expedited through national regulatory protocols, the company accelerated its objective in completing the comprehensive pre-clinical studies. Results from these studies have been promising and show extensive safety and effective immune responses.

Speaking about Bharat Biotech's prowess, Suchitra Ella, Joint Managing Director said, "Our ongoing research and expertise in forecasting epidemics has enabled us to successfully manufacture a vaccine for the H1N1 pandemic."
"Continuing our focus on creating the only BSL-3 containment facilities for manufacturing and testing in India, Bharat Biotech is committed to advancing vaccine development as a matter of national importance to demonstrate India's strength in handling future pandemics," she added.

Bharat Biotech's track record in developing vero cell culture platform technologies has been proven in several vaccines for Polio, Rabies, Rotavirus, Japanese Encephalitis, Chikungunya and Zika.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
May 19,2020

Ahmedabad, Nay 19: Over 2,200 Indian nationals stranded in the UK due to the coronavirus related international travel restrictions have been flown back home during the first phase of India's biggest ever repatriation exercise, according to official figures.

Since the first special Air India flight took off from London’s Heathrow Airport for Mumbai on May 8, there have been eight routes to different Indian cities from the UK for Indian students and tourists.

Indian nationals were flown home to the cities of Mumbai, New Delhi, Bengaluru, Chennai and Ahmedabad.

“We have facilitated repatriation of 2,288 Indians stranded in the UK through eight Air India flights till 17 May. Vande Bharat Mission continues to get Indians home,” said the Indian High Commission in London.

The Vande Bharat Mission is India’s biggest ever repatriation exercise to bring back Indians from abroad who are unable to travel home due to COVID-19 related international travel restrictions.

As the second phase of the repatriation process gets underway, retired Indian High Commissioner to the UK Ruchi Ghanashyam will be among the Indians flying back to New Delhi on Thursday.

“It has been such a hectic period, but I hope to return to the UK to say goodbyes in person sometime in the future,” Ghanashyam said during a virtual farewell organised by the Indian Journalists’ Association (IJA UK) on Monday.

As the packed flights take off daily, there are some still desperately waiting their turn, including those wanting to fly to some cities that are yet to be scheduled, including Kolkata.

“I have two young daughters, elderly parents, and a wife back at home. There is no way to return to Kolkata. I am worried for my parents,” says Suvendu, who came to the UK for work but recently lost his job.

“I am really surprised there are no Kolkata flights yet, but I am hoping they will be announced in the future,” adds Dr Arpita Ray, whose father needs to fly back home.

Another group waiting their turn to return home to their families in India includes students in the Overseas Citizen of India (OCI) category, which remains suspended in India’s extended COVID-19 lockdown.

According to the regulations issued by the Indian government last month and updated last week, visas of foreign nationals and OCI cards, that provide visa-free travel privileges to the people of Indian-origin, have been suspended as part of the new international travel restrictions following the COVID-19 pandemic.

“Our plight is no different from the struggles being faced by Indian students who hold Indian passports – India is home for all us,” says Tridip, an undergraduate at SOAS University of London.

“Yes, air travel at this point of time may be a risk but we are of course ready to take all precautionary measures and undergo the mandatory quarantine period upon arrival in India," adds the 18-year-old.

“Having lived in India for the greater part of my life, India is home to me as much as it is to an Indian citizen, and just as any Indian citizen wishes for the comfort of home and family, so do I. I can only hope that the government reviews its policy on OCI holders and appeal to them to include us in their repatriation plans," says Atulit, an under-graduate student at Imperial College London.

Bianta, a student at Bangor University in Wales, adds: “Along with all of the mental stress, financially the UK is too expensive. In the coming weeks my rental agreement will expire, after which I will have nowhere to go.

“I cannot continue funding myself here in the UK as I only planned to be here till May marking the end of my course. Please help us get home. The colour of my passport does not define where my home is."

As all commercial international flights continue to be grounded, the second phase of the Vande Bharat Mission with a total of 149 flights is aimed at bringing back Indians from 40 countries. On landing in India, these travellers have a 14-day quarantine requirement at venues organised by the respective state governments. 

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.